Core Insights - Eversource Energy (ES) is expected to report quarterly earnings of $1.11 per share, reflecting a 9.9% increase year-over-year, with revenues projected at $3.53 billion, an 18.9% increase compared to the previous year [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised downward by 4.9%, indicating a collective reassessment by analysts of their initial forecasts [2]. - Prior to earnings announcements, revisions to earnings estimates are crucial as they serve as indicators for predicting investor actions regarding the stock [3]. Key Metrics - The consensus estimate for 'Operating Income - Electric Distribution' is $149.77 million, down from $178.10 million year-over-year [5]. - Analysts predict 'Operating Income - Electric Transmission' will reach $304.01 million, up from $276.90 million year-over-year [5]. - The estimated 'Operating Income - Natural Gas Distribution' stands at $157.71 million, compared to $149.60 million from the previous year [6]. Stock Performance - Over the past month, Eversource shares have recorded a return of -1.6%, while the Zacks S&P 500 composite has remained unchanged [6]. - Eversource holds a Zacks Rank of 2 (Buy), suggesting it is likely to outperform the overall market in the upcoming period [6].

Core Viewpoint - Wall Street analysts forecast a slight increase in West Pharmaceutical Services' quarterly earnings and revenues, indicating stable growth in the company's financial performance [1]. Earnings Estimates - Analysts predict quarterly earnings of $1.83 per share, reflecting a year-over-year increase of 0.6% [1]. - Revenue is anticipated to reach $794.26 million, showing a 6.1% increase compared to the same quarter last year [1]. - The consensus EPS estimate has remained unchanged over the past 30 days, indicating analysts' reassessment of their projections [2]. Key Metrics Projections - 'Net Sales- Contract-Manufactured Products' are expected to be $144.45 million, representing a 7.1% increase from the previous year [5]. - 'Net Sales- Proprietary Products' is projected at $648.56 million, indicating a 5.7% increase year-over-year [5]. - 'Change in Organic Revenue' is forecasted to be 1.8%, down from 3.3% in the previous year [5]. Profit Estimates - The estimated 'Gross Profit- Proprietary Products' is $257.16 million, compared to $250.70 million from the previous year [6]. - The consensus estimate for 'Gross Profit- Contract-Manufactured Products' stands at $25.76 million, up from $22.90 million year-over-year [6]. Market Performance - Shares of West Pharmaceutical have experienced a return of -8.8% over the past month, contrasting with the S&P 500 composite's unchanged performance [6]. - The company holds a Zacks Rank 2 (Buy), suggesting expectations of outperforming the overall market in the near future [6].

Core Viewpoint - LendingClub (LC) is experiencing significant selling pressure, with a 24.1% decline over the past four weeks, but is now positioned for a potential trend reversal as it enters oversold territory, supported by analyst expectations of better earnings than previously predicted [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is utilized to determine if a stock is oversold, with readings below 30 indicating oversold conditions [2]. - LC's current RSI reading is 29.23, suggesting that the heavy selling may be exhausting itself, indicating a possible bounce back towards equilibrium in supply and demand [5]. Group 2: Fundamental Indicators - There is a strong consensus among sell-side analysts that earnings estimates for LC have increased by 5.5% over the last 30 days, which typically correlates with price appreciation in the near term [7]. - LC holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [8].

Core Insights - Albemarle (ALB) is expected to report a quarterly loss of -$0.50 per share, which is a 54.1% increase compared to the same period last year [1] - Analysts forecast revenues of $1.35 billion, indicating a year-over-year increase of 9.6% [1] - The consensus EPS estimate has been revised 396.4% higher in the last 30 days, reflecting a significant reevaluation by analysts [1] Revenue Estimates - 'Net Sales- Energy Storage' is projected to reach $716.89 million, representing a 16.2% increase from the year-ago quarter [4] - 'Net Sales- Ketjen' is estimated at $296.35 million, suggesting a 5.1% year-over-year change [4] - 'Net Sales- Specialties' is forecasted to be $348.66 million, indicating a 4.7% increase from the previous year [4] EBITDA Estimates - 'Adjusted EBITDA- Corporate' is expected to be -$15.46 million, contrasting with the year-ago figure of $8.35 million [5] - 'Adjusted EBITDA- Ketjen' is projected at $35.01 million, slightly down from $35.78 million year-over-year [5] - 'Adjusted EBITDA- Specialties' is anticipated to be $52.12 million, down from $72.88 million in the previous year [5] - 'Adjusted EBITDA- Energy Storage' is expected to reach $159.67 million, up from $133.68 million in the same quarter last year [6] Market Performance - Albemarle shares have shown a return of -1.2% over the past month, compared to a -1.5% change in the Zacks S&P 500 composite [6] - With a Zacks Rank 1 (Strong Buy), Albemarle is expected to outperform the overall market in the near future [6]

Core Viewpoint - Equinix (EQIX) is expected to report quarterly earnings of $9.07 per share, a 14.5% increase year-over-year, with revenues projected at $2.47 billion, reflecting a 9.2% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 2.7% in the last 30 days, indicating analysts' reassessment of their initial estimates [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock performance [3]. Revenue Projections - Analysts project 'Revenues- Non-recurring revenues' to reach $184.81 million, marking an 8.7% year-over-year increase [5]. - 'Revenues- Recurring revenues' are expected to be $2.28 billion, with a year-over-year change of 9% [5]. - 'Revenues- Recurring revenues- Managed infrastructure' is estimated at $119.09 million, reflecting a 3.6% increase from the previous year [6]. - 'Revenues- Recurring revenues- Colocation' is forecasted to be $1.69 billion, indicating an 8.9% year-over-year growth [6]. Geographic Revenue Estimates - The consensus for 'Geographic Revenues- Americas' is $1.11 billion, showing an 11% increase from the prior year [7]. - 'Geographic Revenues- Europe- Recurring- Managed infrastructure' is expected to reach $38.68 million, a 13.8% increase year-over-year [7]. - 'Geographic Revenues- EMEA' is projected at $819.56 million, reflecting a 5.6% year-over-year change [7]. Other Key Metrics - 'Geographic Revenues- Americas- Recurring- Other' is estimated at $5.06 million, indicating a significant decline of 27.7% year-over-year [8]. - 'EMEA - Cabinet Equivalent Capacity' is forecasted to be 139,883, up from 138,200 year-over-year [8]. - 'Americas - Quarter End Utilization' is expected to be 80.9%, slightly down from 81.0% the previous year [8]. - 'Americas - Cabinet Equivalent Capacity' is projected at 154,467, an increase from 144,100 year-over-year [9]. - 'Asia-Pacific - Cabinet Billing' is expected to reach 68,687, up from 66,600 in the same quarter last year [9]. Stock Performance - Over the past month, Equinix shares have returned +3.3%, contrasting with the Zacks S&P 500 composite's -1.5% change [9].

Wall Street expects a year-over-year increase in earnings on higher revenues when PG&E (PCG) reports results for the quarter ended December 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on February 12, might help the stock move higher if these key numbers are better than expectations. ...

Core Viewpoint - Analysts project that Fiserv (FISV) will report quarterly earnings of $1.90 per share, reflecting a year-over-year decline of 24.3%, with revenues expected to reach $4.95 billion, a slight increase of 0.9% from the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has been revised 3.3% lower over the past 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Projections - Analysts predict 'Adjusted Revenue- Financial' will be $2.36 billion, a year-over-year decline of 1.5% [5]. - 'Adjusted Revenue- Merchant' is expected to reach $2.55 billion, indicating a year-over-year increase of 2.2% [5]. - 'Revenue- Product' is projected at $999.56 million, reflecting a year-over-year increase of 0.9% [5]. - The consensus estimate for 'Revenue- Processing and services' stands at $4.27 billion, showing a change of +0.1% from the prior-year quarter [6]. - 'Revenue- Corporate and Other' is expected to be $341.38 million, indicating a year-over-year decline of 2.7% [6]. - 'Adjusted Revenue- Financial Solutions- Banking' is projected at $611.10 million, reflecting a year-over-year decline of 3% [6]. - 'Adjusted Revenue- Financial Solutions- Issuing' is expected to reach $798.45 million, indicating a year-over-year increase of 0.3% [7]. - 'Adjusted Revenue- Merchant Solutions- Processing' is projected at $254.48 million, reflecting a year-over-year decline of 2.5% [7]. - 'Adjusted Revenue- Merchant Solutions- Enterprise' is expected to be $628.65 million, indicating a year-over-year increase of 4.8% [7]. - 'Adjusted Revenue- Merchant Solutions- Small Business' is projected at $1.69 billion, reflecting a year-over-year increase of 3% [8]. - 'Adjusted Revenue- Financial Solutions- Digital Payments' is expected to be $926.25 million, indicating a year-over-year decline of 5% [8]. Operating Income - Analysts estimate 'Operating income- Merchant Solutions' will reach $833.87 million, down from $979.00 million reported in the same quarter last year [9]. Stock Performance - Fiserv shares have shown a return of -13.1% over the past month, contrasting with the Zacks S&P 500 composite's +0.5% change, and the stock holds a Zacks Rank 3 (Hold), suggesting it will mirror overall market performance in the near future [10].

Core Viewpoint - Spotify is expected to report a quarterly earnings per share (EPS) of $2.95, marking a 56.9% increase year-over-year, with revenues projected at $5.16 billion, reflecting a 14% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate has been revised down by 7.5% over the last 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings estimates are crucial for predicting investor actions, as empirical research shows a strong correlation between these revisions and short-term stock price performance [3]. Key Metrics Forecast - Total Monthly Active Users (MAUs) are projected to reach 745.41 million, up from 675.00 million in the same quarter last year [5]. - Premium Subscribers are expected to hit 289.27 million, compared to 263.00 million a year ago [5]. - Ad-Supported MAUs are forecasted to reach 470.00 million, an increase from 425.00 million in the previous year [5]. Stock Performance - Spotify shares have decreased by 22.7% in the past month, while the Zacks S&P 500 composite has increased by 0.5% [6]. - With a Zacks Rank of 3 (Hold), Spotify is anticipated to closely follow overall market performance in the near term [6].

分组1 - Omega Healthcare Investors reported quarterly funds from operations (FFO) of $0.8 per share, exceeding the Zacks Consensus Estimate of $0.79 per share, and up from $0.74 per share a year ago, representing an FFO surprise of +1.69% [1] - The company achieved revenues of $319.22 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.06%, and an increase from year-ago revenues of $279.32 million [2] - Over the last four quarters, Omega Healthcare Investors has surpassed consensus FFO estimates three times and revenue estimates two times [2] 分组2 - The stock has underperformed the market, losing about 3.2% since the beginning of the year compared to the S&P 500's gain of 1.1% [3] - The current consensus FFO estimate for the coming quarter is $0.80 on revenues of $325.55 million, and for the current fiscal year, it is $3.26 on revenues of $1.33 billion [7] - The Zacks Industry Rank indicates that the REIT and Equity Trust - Other sector is currently in the bottom 28% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]

Core Insights - Huntington Ingalls (HII) is expected to report quarterly earnings of $3.72 per share, an increase of 18.1% year-over-year, with revenues projected at $3.06 billion, reflecting a 1.7% increase compared to the same period last year [1] Earnings Estimates - The consensus EPS estimate has been revised 0.6% higher in the last 30 days, indicating a collective reevaluation by analysts [2] - Revisions to earnings estimates are significant indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3] Revenue Projections - The consensus estimate for 'Sales and Service Revenues- Mission Technologies' is $763.02 million, indicating a 7% increase from the prior-year quarter [5] - 'Sales and Service Revenues- Ingalls' is projected to reach $702.19 million, suggesting a decrease of 4.6% year-over-year [5] - 'Sales and Service Revenues- Newport News' is expected to be $1.63 billion, reflecting a year-over-year increase of 2.4% [5] Segment Operating Income - Analysts estimate 'Segment Operating Income (loss)- Ingalls' will be $52.95 million, up from $46.00 million in the same quarter last year [6] - 'Segment Operating Income (loss)- Newport News' is projected at $86.76 million, compared to $38.00 million reported in the same quarter last year [6] - 'Segment Operating Income (loss)- Mission Technologies' is expected to reach $29.26 million, an increase from $19.00 million in the same quarter last year [7] - The estimate for 'Operating income (loss)- Operating FAS/CAS Adjustment' is projected at -$10.46 million, down from $14.00 million in the previous year [7] Stock Performance - Over the past month, shares of Huntington Ingalls have returned +16.9%, significantly outperforming the Zacks S&P 500 composite's +0.9% change [7] - Currently, HII holds a Zacks Rank 2 (Buy), suggesting potential outperformance in the near future [7]